In the Matter of Certain Electronic Devices With Multi-Touch Enabled Touchpads and Touchscreens; Notice of Request for Statements on the Public Interest, 30967-30968 [2011-13188]
Download as PDF
Federal Register / Vol. 76, No. 103 / Friday, May 27, 2011 / Notices
Reclamation’s publication of its Buy
American decision is required pursuant
to the Buy American Act, 2 CFR
176.80(b)(2).
Upon publication of this Federal
Register notice, Reclamation is notifying
the public of the decision to approve the
Buy American waiver requested by the
DRC to purchase foreign ductile iron
flanges as part of the American
Recovery and Reinvestment Act of 2009
(ARRA) grant for the TSID Phase III
Main Canal piping project located in
Sisters, Oregon.
Dated: May 20, 2011.
Grayford F. Payne,
Deputy Commissioner—Policy,
Administration and Budget, Bureau of
Reclamation.
[FR Doc. 2011–12997 Filed 5–26–11;8:45 am]
under section 733(b) of the Act, or, if the
preliminary determinations are
negative, upon notice of affirmative
final determinations in the
investigations under section 735(a) of
the Act. Parties that filed entries of
appearance in the preliminary phase of
the investigations need not enter a
separate appearance for the final phase
of the investigations. Industrial users,
and, if the merchandise under
investigation is sold at the retail level,
representative consumer organizations
have the right to appear as parties in
Commission antidumping and
countervailing duty investigations. The
Secretary will prepare a public service
list containing the names and addresses
of all persons, or their representatives,
who are parties to the investigations.
BILLING CODE 4310–MN–P
Background
INTERNATIONAL TRADE
COMMISSION
Investigation Nos. [731–TA–1186–1187]
(Preliminary)
Certain Stilbenic Optical Brightening
Agents From China and Taiwan
Determinations
On the basis of the record 1 developed
in the subject investigation, the United
States International Trade Commission
(Commission) determines, pursuant to
section 733(a) of the Tariff Act of 1930
(19 U.S.C. 1673b(a)) (the Act), that there
is a reasonable indication that an
industry in the United States is
materially injured by reason of imports
from China and Taiwan of certain
stilbenic optical brightening agents,
provided for in subheadings 3204.20.80,
2933.69.6050, 2921.59.40, and
2921.59.8090 of the Harmonized Tariff
Schedule of the United States, that are
alleged to be sold in the United States
at less than fair value (LTFV).
jdjones on DSK8KYBLC1PROD with NOTICES
Commencement of Final Phase
Investigations
Pursuant to section 207.18 of the
Commission’s rules, the Commission
also gives notice of the commencement
of the final phase of its investigations.
The Commission will issue a final phase
notice of scheduling, which will be
published in the Federal Register as
provided in section 207.21 of the
Commission’s rules, upon notice from
the Department of Commerce
(Commerce) of affirmative preliminary
determinations in the investigation
1 The record is defined in section 207.2(f) of the
Commission’s Rules of Practice and Procedure (19
CFR 207.2(f)).
VerDate Mar<15>2010
15:25 May 26, 2011
Jkt 223001
On March 31, 2011, a petition was
filed with the Commission and
Commerce by Clariant Corp., Charlotte,
NC, alleging that an industry in the
United States is materially injured by
reason of LTFV imports of certain
stilbenic optical brightening agents from
China and Taiwan. Accordingly,
effective March 31, 2011, the
Commission instituted antidumping
duty investigation Nos. 731–TA–1186–
1187 (Preliminary).
Notice of the institution of the
Commission’s investigations and of a
public conference to be held in
connection therewith was given by
posting copies of the notice in the Office
of the Secretary, U.S. International
Trade Commission, Washington, DC,
and by publishing the notice in the
Federal Register of April 7, 2011 (76 FR
19383). The conference was held in
Washington, DC, on April 21, 2011, and
all persons who requested the
opportunity were permitted to appear in
person or by counsel.
The Commission transmitted its
determinations in these investigations to
the Secretary of Commerce on May 16,
2011. The views of the Commission are
contained in USITC Publication 4236
(May 2011), entitled Certain Stilbenic
Optical Brightening Agents from China
and Taiwan: Investigation Nos. 731–
TA–1186–1187 (Preliminary).
Issued: May 23, 2011.
By order of the Commission.
James R. Holbein,
Secretary to the Commission.
[FR Doc. 2011–13185 Filed 5–26–11; 8:45 am]
BILLING CODE 7020–02–P
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
30967
INTERNATIONAL TRADE
COMMISSION
[Investigation No. 337–TA–714]
In the Matter of Certain Electronic
Devices With Multi-Touch Enabled
Touchpads and Touchscreens; Notice
of Request for Statements on the
Public Interest
Section 337 of the Tariff Act of 1930
provides that if the Commission finds a
violation it shall exclude the articles
concerned from the United States:
Unless, after considering the effect of such
exclusion upon the public health and
welfare, competitive conditions in the United
States economy, the production of like or
directly competitive articles in the United
States, and United States consumers, it finds
that such articles should not be excluded
from entry.
19 U.S.C. 1337(d)(1). A similar
provision applies to cease and desist
orders. 19 U.S.C. 1337(f)(1).
The Commission is interested in
further development of the record on
the public interest in its investigations.
Accordingly, the parties are invited to
file submissions of no more than five (5)
pages concerning the public interest in
light of the administrative law judge’s
Recommended Determination on
Remedy and Bonding issued in this
investigation on April 29, 2011.
Comments should address whether
issuance of a limited exclusion order
and/or a cease and desist order in this
investigation could affect the public
health and welfare in the United States,
competitive conditions in the United
States economy, the production of like
or directly competitive articles in the
United States, or United States
consumers.
In particular, the Commission is
interested in comments that:
(i) Explain how the articles
potentially subject to the orders are used
in the United States;
(ii) identify any public health, safety,
or welfare concerns in the United States
relating to the potential orders;
(iii) indicate the extent to which like
or directly competitive articles are
produced in the United States or are
otherwise available in the United States,
with respect to the articles potentially
subject to the orders;
(iv) indicate whether Complainant,
Complainant’s licensees, and/or third
party suppliers have the capacity to
replace the volume of articles
potentially subject to an exclusion order
and a cease and desist order within a
commercially reasonable time; and
(v) indicate whether the limited
exclusion order and/or cease and desist
E:\FR\FM\27MYN1.SGM
27MYN1
30968
Federal Register / Vol. 76, No. 103 / Friday, May 27, 2011 / Notices
order could impact United States
consumers.
Any submissions are due on June 6,
2011.
Issued: May 23, 2011.
By order of the Commission.
James R. Holbein,
Secretary to the Commission.
[FR Doc. 2011–13188 Filed 5–26–11; 8:45 am]
BILLING CODE 7020–02–P
INTERNATIONAL TRADE
COMMISSION
[Investigation No. 337–TA–760]
In the Matter of Certain Liquid Crystal
Display Devices, Products Containing
Same, and Methods for Using the
Same; Notice of Commission Decision
Not To Review an Initial Determination
Terminating the Investigation
U.S. International Trade
Commission.
ACTION: Notice.
AGENCY:
Notice is hereby given that
the U.S. International Trade
Commission has determined not to
review the presiding administrative law
judge’s initial determination (‘‘ID’’)
(Order No. 9) granting a joint motion to
terminate the investigation.
FOR FURTHER INFORMATION CONTACT:
Sidney A. Rosenzweig, Office of the
General Counsel, U.S. International
Trade Commission, 500 E Street, SW.,
Washington, DC 20436, telephone (202)
708–2532. Copies of non-confidential
documents filed in connection with this
investigation are or will be available for
inspection during official business
hours (8:45 a.m. to 5:15 p.m.) in the
Office of the Secretary, U.S.
International Trade Commission, 500 E
Street, SW., Washington, DC 20436,
telephone (202) 205–2000. General
information concerning the Commission
may also be obtained by accessing its
Internet server at https://www.usitc.gov.
The public record for this investigation
may be viewed on the Commission’s
electronic docket (EDIS) at https://
edis.usitc.gov. Hearing-impaired
persons are advised that information on
this matter can be obtained by
contacting the Commission’s TDD
terminal on (202) 205–1810.
SUPPLEMENTARY INFORMATION: The
Commission instituted this investigation
on March 2, 2011, based on a complaint
filed by Sharp Corporation of Japan
(‘‘Sharp’’) that named as respondents:
AU Optronics Corp. of Taiwan; AU
Optronics Corporation America of
Houston, Texas; BenQ America of
Irvine, California; BenQ Corporation of
jdjones on DSK8KYBLC1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
15:25 May 26, 2011
Jkt 223001
Taiwan; Haier America Trading LLC, of
New York, New York; Haier Group
Company of China; LG Electronics Inc.
of South Korea; LG Electronics U.S.A.,
Inc. of Englewood Cliffs, New Jersey;
SANYO Electric Co. of Japan; SANYO
North America Corporation of San
Diego, California; TCL Corporation of
China; TTE Technology, Inc. d/b/a TCL
America of Indianapolis, Indiana; and
VIZIO, Inc. of Irvine, California. 76 FR
11512 (Mar. 2, 2011). The complaint
alleged a violation of section 337 of the
Tariff Act of 1930, as amended, 19
U.S.C. 1337, in the importation, sale for
importation, and sale within the United
States after importation of certain liquid
crystal display (‘‘LCD’’) devices,
products containing same, and methods
for using same by reason of the
infringement of certain claims of U.S.
Patent Nos. 6,879,364; 7,304,626;
7,532,183; 7,283,192; 6,937,300;
7,057,689; and 7,838,881.
On April 21, 2011, Sharp and the AU
Optronics respondents (‘‘AUO’’) filed a
joint motion for termination of the
investigation on the basis of settlement
and licensing agreements. No other
party opposed the motion. The
agreements call for Sharp and AUO to
terminate the investigation and to
dismiss parallel district court
proceedings. The other respondents
make or sell products that contain
accused AUO LCD components, and the
settlement between Sharp and AUO
thereby resolved all disputes in the
investigation.
On May 3, 2011, the ALJ granted the
motion as an ID (Order No. 9).
No petitions for review of the ID were
filed. The Commission has determined
not to review the ID.
The authority for the Commission’s
determination is contained in section
337 of the Tariff Act of 1930, as
amended (19 U.S.C. 1337), and in Part
210 of the Commission’s Rules of
Practice and Procedure (19 CFR part
210).
By order of the Commission.
Issued: May 23, 2011.
James R. Holbein,
Secretary to the Commission.
[FR Doc. 2011–13189 Filed 5–26–11; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Application
Pursuant to 21 U.S.C. 958(i), the
Attorney General shall, prior to issuing
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
a registration under this Section to a
bulk manufacturer of a controlled
substance in schedule I or II, and prior
to issuing a regulation under 21 U.S.C.
952(a)(2), authorizing the importation of
such a substance, provide
manufacturers holding registrations for
the bulk manufacture of the substance
an opportunity for a hearing.
Therefore, in accordance with 21 CFR
1301.34(a), this is notice that on March
14, 2011, Almac Clinical Services Inc.
(ACSI), 25 Fretz Road, Souderton,
Pennsylvania 18964, made application
by renewal to the Drug Enforcement
Administration (DEA) to be registered as
an importer of the following basic
classes of controlled substances:
Drug
Schedule
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Tapentadol (9780) ........................
Fentanyl (9801) ............................
II
II
II
II
The company plans to import small
quantities of the listed controlled
substances in dosage form to conduct
clinical trials.
Any bulk manufacturer who is
presently, or is applying to be,
registered with DEA to manufacture
such basic classes of controlled
substances may file comments or
objections to the issuance of the
proposed registration and may, at the
same time, file a written request for a
hearing on such application pursuant to
21 CFR 1301.43, and in such form as
prescribed by 21 CFR 1316.47.
Any such comments or objections
should be addressed, in quintuplicate,
to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than June 27, 2011.
This procedure is to be conducted
simultaneously with, and independent
of, the procedures described in 21 CFR
1301.34(b), (c), (d), (e), and (f). As noted
in a previous notice published in the
Federal Register on September 23, 1975,
40 FR 43745–46, all applicants for
registration to import the basic class of
any controlled substance in schedule I
or II are, and will continue to be,
required to demonstrate to the Deputy
Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to 21
U.S.C. 958(a); 21 U.S.C. 823(a); and 21
CFR 1301.34(b), (c), (d), (e), and (f) are
satisfied.
E:\FR\FM\27MYN1.SGM
27MYN1
Agencies
[Federal Register Volume 76, Number 103 (Friday, May 27, 2011)]
[Notices]
[Pages 30967-30968]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-13188]
-----------------------------------------------------------------------
INTERNATIONAL TRADE COMMISSION
[Investigation No. 337-TA-714]
In the Matter of Certain Electronic Devices With Multi-Touch
Enabled Touchpads and Touchscreens; Notice of Request for Statements on
the Public Interest
Section 337 of the Tariff Act of 1930 provides that if the
Commission finds a violation it shall exclude the articles concerned
from the United States:
Unless, after considering the effect of such exclusion upon the
public health and welfare, competitive conditions in the United
States economy, the production of like or directly competitive
articles in the United States, and United States consumers, it finds
that such articles should not be excluded from entry.
19 U.S.C. 1337(d)(1). A similar provision applies to cease and desist
orders. 19 U.S.C. 1337(f)(1).
The Commission is interested in further development of the record
on the public interest in its investigations. Accordingly, the parties
are invited to file submissions of no more than five (5) pages
concerning the public interest in light of the administrative law
judge's Recommended Determination on Remedy and Bonding issued in this
investigation on April 29, 2011. Comments should address whether
issuance of a limited exclusion order and/or a cease and desist order
in this investigation could affect the public health and welfare in the
United States, competitive conditions in the United States economy, the
production of like or directly competitive articles in the United
States, or United States consumers.
In particular, the Commission is interested in comments that:
(i) Explain how the articles potentially subject to the orders are
used in the United States;
(ii) identify any public health, safety, or welfare concerns in the
United States relating to the potential orders;
(iii) indicate the extent to which like or directly competitive
articles are produced in the United States or are otherwise available
in the United States, with respect to the articles potentially subject
to the orders;
(iv) indicate whether Complainant, Complainant's licensees, and/or
third party suppliers have the capacity to replace the volume of
articles potentially subject to an exclusion order and a cease and
desist order within a commercially reasonable time; and
(v) indicate whether the limited exclusion order and/or cease and
desist
[[Page 30968]]
order could impact United States consumers.
Any submissions are due on June 6, 2011.
Issued: May 23, 2011.
By order of the Commission.
James R. Holbein,
Secretary to the Commission.
[FR Doc. 2011-13188 Filed 5-26-11; 8:45 am]
BILLING CODE 7020-02-P